Allogene Therapeutics ALLO
NASDAQ ALLO
$1.54 -0.06 (-3.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Return on Assets [ROA] (2018 - 2026)

Updated

Allogene Therapeutics' Return on Assets [ROA] was -35.05% in Q2 2026, up 12.66 percentage points from -47.71% a year earlier and up 7.83 percentage points from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Allogene Therapeutics came in at -39.58%, up 3.66 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of -13.86 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -43.24% in FY2024 (+1.46 pp), -44.70% in FY2023 (-9.34 pp), -35.35% in FY2022 (-12.79 pp) and -22.56% in FY2021 (+3.16 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q3 2022.
  • Compared with a year earlier, Return on Assets [ROA] was higher in three of the last eight quarters, with an average year-over-year change of +1.09 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 12.66 percentage points); the worst was Q1 2023 (a drop of 22.13 percentage points).
  • Per Business Quant data, ALLO's Return on Assets [ROA] in the three quarters before Q2 2026 was -42.89% (Q1 2026), -44.67% (Q4 2025) and -46.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Allogene Therapeutics 552.55 Mn 552.55 Mn - -35.05%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.05%
Mar 31, 2026 -42.89%
Dec 31, 2025 -44.67%
Sep 30, 2025 -46.04%
Jun 30, 2025 -47.71%
Mar 31, 2025 -47.12%
Dec 31, 2024 -44.51%
Sep 30, 2024 -44.42%
Jun 30, 2024 -43.16%
Mar 31, 2024 -44.98%
Dec 31, 2023 -45.63%
Sep 30, 2023 -43.62%
Jun 30, 2023 -45.82%
Mar 31, 2023 -44.34%
Dec 31, 2022 -38.57%
Sep 30, 2022 -25.45%
Jun 30, 2022 -23.91%
Mar 31, 2022 -22.21%
Dec 31, 2021 -16.81%
Sep 30, 2021 -22.62%
API Access

Allogene Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ALLO&period=max&api_key=YOUR_API_KEY